We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Cardiology

Journal Scan / Research · February 05, 2020

Electrical vs Pharmacological Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation

The Lancet

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Electrical Versus Pharmacological Cardioversion for Emergency Department Patients With Acute Atrial Fibrillation (RAFF2): A Partial Factorial Randomised Trial
Lancet 2020 Feb 01;[EPub Ahead of Print], IG Stiell, MLA Sivilotti, M Taljaard, David Birnie, A Vadeboncoeur, CM Hohl, AD McRae, BH Rowe, RJ Brison, V Thiruganasambandamoorthy, L Macle, B Borgundvaag, J Morris, E Mercier, CM Clement, J Brinkhurst, C Sheehan, E Brown, M-Joe Nemnom, GA Wells, JJ Perry

Further Reading